MetFORMIN hydrochloride 500 mg / SITagliptin phosphate 50 mg Oral Tablet
RxNorm 2709491
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2709491 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metFORMIN hydrochloride 500 mg / SITagliptin phosphate 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Metformin hydrochloride 500 mg / sitagliptin phosphate 50 mg Oral Tablet
(Atom ID: 12956911)
PSNPrescribable
Prescribable Name (PSN):
MetFORMIN hydrochloride 500 mg / SITagliptin phosphate 50 mg Oral Tablet
(Atom ID: 12956927)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetFORMIN hydrochloride 500 mg / SITagliptin phosphate 50 mg Oral Tablet
(Atom ID: 12957333)
PTPrescribable
Designated preferred name (PT):
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet
(Atom ID: 12756322)
FNPrescribable